ISSN: 0973-7510

E-ISSN: 2581-690X

Mini Review | Open Access
S.S. Jaya Lakshmi and K.V. Leela
Department of Microbiology, SRM Medical College Hospital and Research Centre, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology, SRM Nagar, Kattankulathur – 603 203, Chengalpattu, Tamil Nadu, India.
Article Number: 7660 | © The Author(s). 2022
J Pure Appl Microbiol. 2022;16(3):1590-1594. https://doi.org/10.22207/JPAM.16.3.26
Received: 09 March 2022 | Accepted: 26 June 2022 | Published online: 03 August 2022
Issue online: September 2022
Abstract

Viridans streptococci are important causative organism of infective endocarditis, which is a disease having long-lasting effects among the patients who live with the disease as well as those who are cured. Infective endocarditis due to viridans streptococci generally usually affects persons with structural heart disease and is also associated with intravascular prosthetic devices. After the onset of bacteremia with the pathogenic viridans streptococci, vegetation is formed in one or more heart valves. The diagnosis of infective endocarditis due to viridans streptococci is difficult to establish in patients with underlying risk factors and it involves the correlation of microbiological (in-vitro growth of viridans streptococci), clinical, and echocardiography results (modified Duke criteria). The common microorganisms are Staphylococcus spp., Enterococcus spp followed by viridans streptococci. The details of viridans streptococci causing infective endocarditis were reviewed in detail. Viridans streptococci possess a challenge in identification up to its species level and which helps in the identification of the source of infection as well as treating the infection.

Keywords

Infective Endocarditis, S. mitis Group, Bacteremia, Viridans Streptococci, Platelet–fibrin Thrombus, S. anginosus Group, MALDI TOF–MS, S. salivarius Group

Introduction

The antigenically and biochemically diverse group of organisms causing oral and gastrointestinal infections are grouped into viridians streptococci, which also includes agents causing bacterial endocarditis.1 Viridans streptococci are alpha-hemolytic streptococci. It is one of the causative agents of infective endocarditis. The risk factors causing infective endocarditis are age >60 years, dental caries or poor dental hygiene, acquired valvular diseases. prosthetic heart valves, congenital heart defects, intravenous drug users and previous history of bacterial endocarditis.2 Infective endocarditis affects the endothelium of the heart and is due to bacteria when introduced into the bloodstream. Various infectious etiology contribute to causing infective endocarditis.3 It is due to minor injury during tooth brushing, poor dental hygiene, chronic skin infections, and implanted devices, viridans streptococci which lodge on the heart valves leading to infection of the endocardium.4

Infective endocarditis
Infective endocarditis can be broadly classified into two types based on the duration of illness, which is due to the injury to the heart endothelium. They are acute, subacute, and chronic infective endocarditis. In acute infective endocarditis, the onset of the disease is within a few days, and it can be life-threatening. The patient generally presents with high-grade fever, persistent cough, palpitations, and swelling of the feet. In subacute or chronic infective endocarditis disease develops slowly and presents after weeks to several months. The patient presents with mild fever, fatigue, sweating, anaemia, and weight loss.5

Causative organisms of Infective endocarditis

  1. Native valve endocarditis: (i) Hospital-acquired: Staphylococcus aureus, Coagulase Negative Staphylococcus, Enterococcus spp., viridans streptococci, Candida spp. (ii) Community-acquired: viridans streptococci, Coagulase Negative Staphylococcus, Enterococcus spp., and S. aureus.6
  2. Prosthetic valve endocarditis: Coagulase Negative Staphylococcus, viridans streptococci, Enterococcus spp., S. aureus, Pseudomonas spp.7

Updated species of viridans streptococci
The various species of viridans streptococci contribute to causing infective endocarditis are listed in Table. This is the current updated (2022) grouping of viridans streptococci 8 and they are grouped into 5 groups namely,

(i)    S. mitis group
(ii)   S. anginosus group
(iii)  S. mutans group
(iv)  S. salivarius group
(v)   S. bovis groups

Table:
Various species of viridans streptococci9,10.

S. mitis group*
S. anginosus group
S. mutans group
S.salivarius group
S. bovis group
S. mitis
S. anginosus subsp. anginosus
S. mutans
S. salivarius subsp. salivarius
S. equinus (S. bovis)
S. infantis
S. anginosus subsp. whileyi
S. criceti
S. salivarius subsp. thermophilus
S. gallolyticus subsp. gallolyticus
S. sanguinis
S. constellatus subsp. constellatus
S. downei
S. vestibularis
S. gallolyticus subsp. pasteurianus
S. parasanguinis
S. constellatus subsp. pharyngis
S. ratti
S. gallolyticus subsp. macedonicus
S. pneumoniae
S. constellatus subsp. viborgensis
S. sobrinus
S. infantarius subsp. infantarius
S. pseudo pneumoniae
S. intermedius
S. infantarius subsp. coli
S.australis
S. alactolyticus
S. cristatus
S. gordonii
S. lactarius
S. massiliensis
S. oralis subsp. oralis
S. oralis subsp. tigurinus
S. oralis subsp. dentisani
S. peroris
S. rubneri
S. sinensis

* Excluding veterinary species

Pathogenesis of viridans streptococci
The above-mentioned risk factors contribute to the invasion of viridians streptococci into the bloodstream. This leads to direct injury of the inner lining of the heart muscle (endocardium) of heart. The initial phase is the preparation of the cardiac valve for bacterial adherence, followed by adhesion of circulating bacteria to the prepared valvular surface and finally survival of the adherent bacteria on the surface, with the propagation of the infected vegetation.11 The alteration in the endothelial cells leads to either disruption of the surface and deposition of platelets and fibrin or other phenomena that render the surface susceptible to colonization by circulating bacteria. Bacterial colonization of vegetation leads to the formation of platelet–fibrin thrombus, due to transient bacteremia.12 The formation of fibrin clots encasing the vegetation guides to valve destruction with loss of function. In the case of underlying structural heart disease and patients with the absence of host defenses, viridans streptococci proliferate forming small vegetations and it is shed into the bloodstream.13

Laboratory diagnosis of viridans streptococci
It involves the isolation of viridans streptococci from the blood culture collected under aseptic conditions. Two sets of the blood sample are drawn more than 12 hours apart or three/four separate blood samples, with the first and last drawn at least 1 hour apart according to modified Duke criteria to arrive at a diagnosis of infective endocarditis.14

Viridans streptococci show general characteristics similar to other streptococcal species. They are facultative anaerobes and catalase-negative. Gram staining shows Gram-positive spherical cocci in long chains. In blood agar, it produces alpha-hemolytic colonies. These bacteria can be differentiated from S. pneumoniae by optochin resistance, bile insolubility, inulin non-fermenter,15 absence of capsule, and arrangement, i.e., cocci in chains (whereas S. pneumoniae are diplococci).16 On a liquid medium, it shows granular turbidity. Viridans streptococci have no Lancefield antigen on the cell wall. Hence they are not classified serologically.16

After the conventional techniques of identification of the alpha-hemolytic colonies, they are subjected to species-level identification using MALDI-TOF MS: The bioMerieux VITEK® MS (MALDI-TOF MS) system,17 Matrix-Assisted Laser Desorption Ionization–Time of Flight based on mass spectrometry. Updated version 3.2 software of Vitex-2 MS identifies most of the pathogenic viridans streptococci species.18 The commonly associated species with infective endocarditis are S. anginosus subsp. anginosus, S. gallolyticus, S. infantarius subsp. coli and S. sanguinis. Identification up to species level of viridans streptococci is so challenging.19

Declarations

ACKNOWLEDGMENTS
None.

CONFLICT OF INTEREST
The authors declare that there is no conflicts of interest.

AUTHORS’ CONTRIBUTION
Both authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.

FUNDING
None.

DATA AVAILABILITY
The data generated during and/or analysed during this review are available from the corresponding author on reasonable request.

ETHICS STATEMENT
Not applicable.

References
  1. Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association [published correction appears in Circulation. 2021;144(9):e192] [published correction appears in Circulation. 2022 Apr 26;145(17):e868]. Circulation. 2021;143(20):e963-e978.
    Crossref
  2. Abhilash KPP, Patole S, Jambugulam M, et al. Changing Trends of Infective Endocarditis in India: A South Indian Experience. J Cardiovasc Dis Res. 2017;8:56-60.
    Crossref
  3. Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139-149.
    Crossref
  4. Nappi F, Singh SSA, Nappi P, et al. Heart Valve Endocarditis. Surg Technol Int. 2020;37:203-215. PMID: 32520388
  5. Rogolevich VV, Glushkova TV, Ponasenko AV, Ovcharenko EA. Kardiologiia. 2019;59(3):68-77.
    Crossref
  6. Knoll B, Tleyjeh IM, Steckelberg JM, Wilson WR, Baddour LM. Infective endocarditis due to penicillin-resistant viridans group streptococci. Clin Infect Dis. 2007;44(12):1585-1592.
    Crossref
  7. Luk A, Kim ML, Ross HJ, Rao V, David TE, Butany J. Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature. Malays J Pathol. 2014;36(2):71-81. PMID: 25194529
  8. Jensen A, Scholz CFP, Kilian M. Re-evaluation of the taxonomy of the Mitis group of the genus Streptococcus based on whole genome phylogenetic analyses, and proposed reclassification of Streptococcus dentisani as Streptococcus oralis subsp. dentisani comb. nov., Streptococcus tigurinus as Streptococcus oralis subsp. tigurinus comb. nov., and Streptococcus oligofermentans as a later synonym of Streptococcus cristatus. Int J Syst Evol Microbiol. 2016;66(11):4803-4820.
    Crossref
  9. Richter SS, Warnock DW (Eds.) 2019. Manual of clinical microbiology. John Wiley & Sons.
    Crossref
  10. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology E-book. Elsevier Health Sciences; 2020.
  11. Ruhayel SD, Foley DA, Hamilton K, et al. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia. Pediatr Infect Dis J. 2021;40(9):832-834.
    Crossref
  12. Liu J, Frishman WH. Nonbacterial Thrombotic Endocarditis: Pathogenesis, Diagnosis, and Management. Cardiol Rev. 2016;24(5):244-247.
    Crossref
  13. Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387(10021):882-893.
    Crossref
  14. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633-638.
    Crossref
  15. Suzuki N, Seki M, Nakano Y, Kiyoura Y, Maeno M, Yamashita Y. Discrimination of Streptococcus pneumoniae from viridans group streptococci by genomic subtractive hybridization. J Clin Microbiol. 2005;43(9):4528-4534.
    Crossref
  16. Leber AL. Clinical microbiology procedures handbook. John Wiley & Sons. 2020.
  17. Singhal N, Kumar M, Kanaujia PK, Virdi JS. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol. 2015;6:791.
    Crossref
  18. Lay Jr JO. MALDI-TOF mass spectrometry of bacteria. Mass Spectrometry Reviews. 2001;20(4):172-94.
    Crossref
  19. Finn T, Schattner A, Dubin I, Cohen R. Streptococcus anginosus endocarditis and multiple liver abscesses in a splenectomised patient. BMJ Case Rep. 2018;2018:bcr2018224266.
    Crossref

Article Metrics

Article View: 214

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.